| Also known as |
Amlodipine besylate (when combined with besylate salt) |
| Blood pressure |
Reduces blood pressure |
| Chemical name |
3-Ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Dosage (medical) |
Typically 5 mg once daily, may be increased to 10 mg depending on patient response |
| Dosage (sports) |
Not applicable |
| Effects |
Lowering blood pressure, increasing blood flow |
| Formula |
C20H25ClN2O5 |
| Half-life |
30-50 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not typically required |
| Main action |
Vasodilator |
| Raw Material |
Amlodipin |
| Side effects |
Headache, swelling, fatigue, abdominal pain, dizziness |
| Storage conditions |
Store at room temperature, away from moisture and light |
| Substance class |
Calcium channel blocker |
| Trade name |
Norvasc, among others |
| Use in sports |
Not typically used in sports |
| Water Retention |
Can cause mild water retention |
| Manufacturer |
Pfizer |
| Packing |
30 tabs (10 mg/tab) |
